METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS T-CELL IMMUNOTHERAPY

Title:

METHODS OF TREATMENT USING A GENETICALLY MODIFIED AUTOLOGOUS T-CELL IMMUNOTHERAPY

Document Type and Number:

WIPO Patent Application WO/2021/072044

Kind Code:

A8

Abstract:

Methods of treating cancer with a precision genome engineered NeoTCR Product are described herein.

More Like This:

WO/1989/010129	PHARMACEUTICAL COMPOSITION CONTAINING DEOXYRIBONUCLEOSIDES FOR WOUND HEALING
WO/2022/115545	PYRIDYLPYRIDONE DERIVATIVES AS VSP34 INHIBITORS FOR USE IN THE TREATMENT OF A VIRAL INFECTION
JP4846151	Use of treosulfan for patient conditioning prior to bone marrow or blood stem cell transplantation

Inventors:

SENNINO BARBARA (US)
PURANDARE BHAMINI (US)
MANDL-CASHMAN STEFANIE (US)
FINE GREGG (US)
RAO ARATI (US)
STALLINGS-SCHMITT TODD (US)
FROHLICH MARK (US)
FRANZUSOFF ALEX (US)

Application Number:

PCT/US2020/054732

Publication Date:

June 03, 2021

Filing Date:

October 08, 2020

Export Citation:

Click for automatic bibliography generation Help

Assignee:

PACT PHARMA INC (US)

International Classes:

A61K45/06; A61K38/20; A61K39/00; A61P35/00; A61P35/04

Attorney, Agent or Firm:

LENDARIS, Steven, P. et al. (US)

Download PDF:

View/Download PDF PDF Help

Previous Patent: ENHANCED OIL RECOVERY METHODS AND COMPOSITIONS

Next Patent: THERAPEUTIC CANNABIS EXTRACTS